Foreign investment updates about pharmaceutical and biotechnology
Update
Alstom, a global leader in smart and sustainable mobility solutions, is making a significant investment in its Hungarian bogie frame factory located in Mátranovák. Through a HUF 6 billion (€15.4 million) development program launched as part of the Mátranovák 2030 Programme, the company aims to boost production capacity by
Update
AstraZeneca, a global leader in biopharmaceutical research, recently signed a cooperation agreement with the Wuxi National High-Tech Industrial Development Zone Management Committee to invest $475 million in building a new small molecule drug factory in Wuxi. The groundbreaking ceremony for the new factory was also held today. This is another
Update (Divestment)
On 30 March 2023, Moderna announced it had finalized an agreement with the Government of Kenya to establish an mRNA manufacturing facility in the country. One year later on 11 April 2024, Moderna announced a temporary halt on building an mRNA vaccine manufacturing facility in Kenya. This decision comes after
Update
Moderna, a leading biotechnology company specializing in mRNA therapeutics and vaccines, has finalized an agreement with the Government of Kenya to establish an mRNA manufacturing facility in the country, marking its first such facility in Africa. This partnership aims to provide Kenya and the African continent access to mRNA vaccines,